Back to Search
DR. JEFFREY BARTSCH M.D.
M.D.
Anesthesiology Physician
NPI: 1861807653IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
ML60563871(WA)TL.0005373(CO)
Anesthesiology PhysicianPrimary
Anesthesiology
Code: 207L00000X
MD60864179(WA)
Education
UNIVERSITY OF COLORADO SCHOOL OF MEDICINE, DENVER
Class of 2014
Research & Publications (20)
ADAM8/MS2/CD156, an emerging drug target in the treatment of inflammatory and invasive pathologies.
PMID 19601829·Curr Pharm Des·2009
6-review
A swine model of pseudo-pulseless electrical activity induced by partial asphyxiation.
PMID 18502560·Resuscitation·2008
7-preclinical
Regulated expression of ADAM8 (a disintegrin and metalloprotease domain 8) in the mouse ovary: evidence for a regulatory role of luteinizing hormone, progesterone receptor, and epidermal growth factor-like growth factors.
PMID 18287572·Biol Reprod·2008
7-preclinical
The ADAM10 prodomain is a specific inhibitor of ADAM10 proteolytic activity and inhibits cellular shedding events.
PMID 17895248·J Biol Chem·2007
7-preclinical
Identification of candidate substrates for ectodomain shedding by the metalloprotease-disintegrin ADAM8.
PMID 16542157·Biol Chem·2006
8-other
Metalloproteinase disintegrins ADAM8 and ADAM19 are highly regulated in human primary brain tumors and their expression levels and activities are associated with invasiveness.
PMID 16772875·J Neuropathol Exp Neurol·2006
4-observational
SH3P7/mAbp1 deficiency leads to tissue and behavioral abnormalities and impaired vesicle transport.
PMID 16601697·EMBO J·2006
7-preclinical
Focal cerebral ischemia induces changes in both MMP-13 and aggrecan around individual neurons.
PMID 16112096·Brain Res·2005
4-observational
ADAM proteins as therapeutic targets in loosening of total hip replacement implants?
PMID 16206338·J Rheumatol·2005
8-other
Metalloprotease-disintegrin ADAM8: expression analysis and targeted deletion in mice.
PMID 15580619·Dev Dyn·2005
7-preclinical
Ectodomain shedding of the neural recognition molecule CHL1 by the metalloprotease-disintegrin ADAM8 promotes neurite outgrowth and suppresses neuronal cell death.
PMID 14761956·J Biol Chem·2004
7-preclinical
An investigation of liquid carryover and sample residual for a high-throughput flow cytometer sample delivery system.
PMID 15228359·Anal Chem·2004
8-other
Adhesion and migration of extracellular matrix-stimulated breast cancer.
PMID 12697413·J Surg Res·2003
8-other
Transcriptional regulation of cytosol and membrane alanyl-aminopeptidase in human T cell subsets.
PMID 12751795·Biol Chem·2003
8-other
Genetic modifiers that aggravate the neurological phenotype of the wobbler mouse.
PMID 11930176·Neuroreport·2002
7-preclinical
The metalloprotease disintegrin ADAM8. Processing by autocatalysis is required for proteolytic activity and cell adhesion.
PMID 12372841·J Biol Chem·2002
7-preclinical
Progressive loss of striatal neurons causes motor dysfunction in MND2 mutant mice and is not prevented by Bcl-2.
PMID 12009762·Exp Neurol·2002
7-preclinical
The genomic basis of K(V)3.4 potassium channel mRNA diversity in mice.
PMID 11245975·Gene·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1035 116TH AVE NE
BELLEVUE, WA 98004 - Phone
- (425) 688-5000
Quick Facts
- NPI
- 1861807653
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 12
- Publications
- 20
Are you this provider?
Claim Your Profile